BNTX original breakout Trades that will make you money. The BNTX charts gave us a beautiful tight range and BOOM! Made two moves from flags - 100% each.
22UA trade ideas
time to buy bntxit's time to buy bntx because it's dropped to a lot in a short time so it will go up approximated as before
Gap Down, Double Bottomwell, didn't give any opportunity to short it. Opened up with a Gap down, made a double bottom and reversed. We are in Wave B now.
Plan for tomorrowWe probably are going to see another dip from here to take it down to $300. If it stay below the channel, i will look for opportunities to short.
Great company but highly overrated stock priceBioNTech was a nobody until they made in just one weekend THE mRNA vaccine everyone spoke about for almost a year.
They have some big brains out there and they have huge potential but right now, it's just the potential because they aren't really producing the vaccine, Pfizer does it because they have the proper facilities and logistics this vaccine requires.
Sorry NASDAQ:BNTX but you need a reality check and I'm sure it will happen after the quarterly report on Monday. $84B company. Like... REALY?!
Buckle up!
Targets for next few daysWe are still in Wave A and completing Sub Wave 3. Expect a choppy upmove for few hours for Wave 4 followed by another leg down. I think 330 could be a reasonable target for this wave A
BNTX I am shortUsing simple RSI 1 day 1 week and 1 month candle
i have taken a short position and will hold for correction
Might be the interim Top hereLooks like we might have the ATH as of yesterday for Wave 3 and might spend sometime in Wave 4 correction. I still have my shorts open, not doing so well but not taking any further position yet.
#bntx #bearish#bntx #bearish A bearish divergence has formed on the weekly chart. The upward movement began to fade.
Big Crash Incoming On BNTXThere will most likely be a 25% to 35% drop in BNTX over a very short period of time.
If we gap down Tuesday then expect it to drop the whole day.
Reasons: Price and volume divergence, over-extesnion of price and emotions, demand imbalances are way lower, topping formations intra-day.
BioNTech $BNTX making a breakout from flag patternNASDAQ:BNTX is in a strong uptrend, and last week tested its 50 day MA and its bouncing really good. Today is in focus as the price broke out a continuation pattern with good volume. Also, the MACD is close to make a buy signal with a bullish crossover.
BioNTech has a IBD relative strength rating of 97 and is Rank #2 in its industry, just behind NASDAQ:REGN which doesn't have good technicals.
With this buy signal I have a target sell on $266.50 with a 2:1 risk/reward ratio.
In search for the next BNTX, MRNA and NVAX !!Since Covid-19 is here to stay with us with its variants and the vaccines don`t offer lifetime protection, this means that there is room for other companies to develop a better vaccine to address the problem.
And the gains in vaccines stock are quite similar to cryptocurrencies year over year.
From all time low to all time high, BNTX made 19X, MRNA 24X and NVAX 66X.
My question for you is the following: which is the next vaccine developer to make at least 10X our money?? I`m looking forward to discover with you the next big vaccine developer!
And i have a presumption or two which i already shared in my group. And those were the fundamentals i was searching for: data submitted to FDA for Emergency Use Authorization, Phase 3, low Market cap - under 1Bil, on the lower end of 52 Week Range, other drugs in the pipeline, high intraday volume.
BioNTech on it's way to new highsPositive Outlook: New ATH
Indicators: Neutral to Bullish
Trend: overall bullish
Stop-Loss: 180 EUR
Target: 220 - 240 EUR
BioNTech got the approval for it's vaccine (for the use for children at 12 or older) from the EMA end ofMay. This boosted the stock above the resistance at 169 EUR which would break the first range it's trading in. The second, much larger range, was beaten a few days after. It's defined by an inside bar on the daily view. Because of this, a fallback into that range could lead to larger consolidation. Therefore, we put our stop loss just below the last ATH. Target remains in the area between the 38,2 and 61,8 Fib (220 - 240 EUR). Next few days (1-2) will be a little bit of Mid-Consolidation before picking up again.
Let's see what happens.
BioNTech could break the wide range upwardNeutral Outlook: Trading in a wide range
Indicators: Neutral to Bullish
Trend: overall bullish
Stop-Loss: 140 EUR
Target: 220 - 240 EUR
BioNTech will get the approval or denial for it's vaccine (for the use for children at 12 or older) from the EMA today. This could boost the stock above the resistance at 169 EUR which would break the first range it's trading in. The second, much larger range is between the ATH (185 EUR) and 121 EUR. It's defined by an inside bar on the daily view. Considering the approval, the overall market and news flow for vaccines and the cheap valuation of BioNTech I would risk a shot here. Stop-Loss should be below the first range line at 140 EUR. Target is the area between the 38,2 and 61,8 Fib (220 - 240 EUR).
Let's see what happens.
$BNTX with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BNTX after a Positive over reaction following its earnings release placing the stock in drift B
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
Biontech with a target of 225€ for JuneBiontech had a run of 135% from April to May but also tanked up to -35% in a short period of time due to the Biden patent waive statement.
Nevertheless, the FUD is over, we are still in a bullish momentum and the fundamentals are looking better than ever.
Bear in mind, I'm drawing only charts here, eventhough my bullish forecast is also backed by the earning reports of Pfizer and Biontech itself. I won't post any numbers or calculations. Everyone has to do its own due dilligence. All I can say is, that the stock is undervalued at this prices currently.
My long term targets are also higher than 225€. But for now I go with 225€ for early June. I also think that the price will leap up from quarter reports to quarter reports.
To the chart:
After the big -35% drop we had a real strong buy back, which is showing still a bullish momentum.
Currently, we are forming a bullish pennant. If we measure the height of it and project it of a break out, we'll get a target nearby. 225€.
The yellow, orange and red wave are messured wave extentions which are all targeting the same price range nearby 225€.
We have not many resistances ahead of us currently. There is the last ATH of 185€ and at the same price range, the median line of the parallel channel. Breaking above it, would head us direclty to the upper boundary of the parallel channel at 225€.
Risk:
Forecasting a price target to a specific date is higly speculative and there is a high likelihood that I will be wrong.
The stock price is highly manipulated due to the overall sentiment and external news.
Eventhough the fundamentals are bullish, we could have a longer period of sidewards movement. That would change the outcome of the predicted target.
Do your own due dilligence!
